[
  {
    "ts": null,
    "headline": "FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC Continues Lead Plaintiff Search for Viatris Inc. (VTRS) Securities Fraud Class Action",
    "summary": "NEW YORK and NEW ORLEANS, May 23, 2025 /PRNewswire/ -- Kahn Swick & Foti, LLC and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors with losses in excess of...",
    "url": "https://finnhub.io/api/news?id=4e6832e2268f93fe303e84ba8efb9f0aaeb5a82c878e24014313d7a0a00ceece",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1748040666,
      "headline": "FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC Continues Lead Plaintiff Search for Viatris Inc. (VTRS) Securities Fraud Class Action",
      "id": 134684518,
      "image": "",
      "related": "VTRS",
      "source": "Finnhub",
      "summary": "NEW YORK and NEW ORLEANS, May 23, 2025 /PRNewswire/ -- Kahn Swick & Foti, LLC and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors with losses in excess of...",
      "url": "https://finnhub.io/api/news?id=4e6832e2268f93fe303e84ba8efb9f0aaeb5a82c878e24014313d7a0a00ceece"
    }
  },
  {
    "ts": null,
    "headline": "Why Investors Should Watch Teva Despite Regional Risks",
    "summary": "Teva Pharmaceuticals continues to beat consensus estimates, has once again raised its 2025 financial guidance and secured credit upgrades. Read more on why TEVA stock is a Buy.",
    "url": "https://finnhub.io/api/news?id=cf24b2a0bb360e2a3e02f53e94632fe654e0bd890ffdc8997680f5ed687da4e5",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1748004723,
      "headline": "Why Investors Should Watch Teva Despite Regional Risks",
      "id": 134667049,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1206782047/image_1206782047.jpg?io=getty-c-w1536",
      "related": "VTRS",
      "source": "SeekingAlpha",
      "summary": "Teva Pharmaceuticals continues to beat consensus estimates, has once again raised its 2025 financial guidance and secured credit upgrades. Read more on why TEVA stock is a Buy.",
      "url": "https://finnhub.io/api/news?id=cf24b2a0bb360e2a3e02f53e94632fe654e0bd890ffdc8997680f5ed687da4e5"
    }
  },
  {
    "ts": null,
    "headline": "VTRS Investors Have Opportunity to Lead Viatris Inc. Securities Fraud Lawsuit with the Schall Law Firm",
    "summary": "LOS ANGELES, May 23, 2025 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Viatris Inc. for violations of...",
    "url": "https://finnhub.io/api/news?id=6c34ca2d11b2bb841880e3da817e855d16079c7f3c675e269b34a19c558908c0",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747992545,
      "headline": "VTRS Investors Have Opportunity to Lead Viatris Inc. Securities Fraud Lawsuit with the Schall Law Firm",
      "id": 134659802,
      "image": "",
      "related": "VTRS",
      "source": "Finnhub",
      "summary": "LOS ANGELES, May 23, 2025 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Viatris Inc. for violations of...",
      "url": "https://finnhub.io/api/news?id=6c34ca2d11b2bb841880e3da817e855d16079c7f3c675e269b34a19c558908c0"
    }
  },
  {
    "ts": null,
    "headline": "Shareholders of Viatris Inc. Should Contact Levi & Korsinsky Before June 3, 2025 to Discuss Your Rights - VTRS",
    "summary": "NEW YORK, May 23, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Viatris Inc. of a class action securities lawsuit. ...",
    "url": "https://finnhub.io/api/news?id=45b928075f2e03ea827b606d426e3e09b03d55a3598cefee670df16c6e8d683c",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747979170,
      "headline": "Shareholders of Viatris Inc. Should Contact Levi & Korsinsky Before June 3, 2025 to Discuss Your Rights - VTRS",
      "id": 134656927,
      "image": "",
      "related": "VTRS",
      "source": "Finnhub",
      "summary": "NEW YORK, May 23, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Viatris Inc. of a class action securities lawsuit. ...",
      "url": "https://finnhub.io/api/news?id=45b928075f2e03ea827b606d426e3e09b03d55a3598cefee670df16c6e8d683c"
    }
  },
  {
    "ts": null,
    "headline": "3 Stocks Under $10 Skating on Thin Ice",
    "summary": "Stocks under $10 pique our interest because they have room to grow (as well as the most affordable option contract premiums). That doesn’t mean they’re bargains though, and we urge investors to be careful as many have risky business models.",
    "url": "https://finnhub.io/api/news?id=2ce6ed6f011323e07f54caa9dfc10e29ac4f80d86d5dfd14eea98ed12581a623",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747974717,
      "headline": "3 Stocks Under $10 Skating on Thin Ice",
      "id": 134659289,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "VTRS",
      "source": "Yahoo",
      "summary": "Stocks under $10 pique our interest because they have room to grow (as well as the most affordable option contract premiums). That doesn’t mean they’re bargains though, and we urge investors to be careful as many have risky business models.",
      "url": "https://finnhub.io/api/news?id=2ce6ed6f011323e07f54caa9dfc10e29ac4f80d86d5dfd14eea98ed12581a623"
    }
  },
  {
    "ts": null,
    "headline": "Generic Pharmaceuticals Stocks Q1 In Review: Amphastar Pharmaceuticals (NASDAQ:AMPH) Vs Peers",
    "summary": "Wrapping up Q1 earnings, we look at the numbers and key takeaways for the generic pharmaceuticals stocks, including Amphastar Pharmaceuticals (NASDAQ:AMPH) and its peers.",
    "url": "https://finnhub.io/api/news?id=9e9b8ea0a159149e0addb16178852bb4499f9dd16eb60660636e10c3f45a487c",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747971367,
      "headline": "Generic Pharmaceuticals Stocks Q1 In Review: Amphastar Pharmaceuticals (NASDAQ:AMPH) Vs Peers",
      "id": 134659290,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "VTRS",
      "source": "Yahoo",
      "summary": "Wrapping up Q1 earnings, we look at the numbers and key takeaways for the generic pharmaceuticals stocks, including Amphastar Pharmaceuticals (NASDAQ:AMPH) and its peers.",
      "url": "https://finnhub.io/api/news?id=9e9b8ea0a159149e0addb16178852bb4499f9dd16eb60660636e10c3f45a487c"
    }
  }
]